The Life Sciences Sector businesses supply a range of medical devices, consumables, instrumentation and related services to Healthcare and Environmental end markets.
Year Ended 30 Sept
| FY 2021 | FY 2020 | ||
| Revenue | £180.4m | £139.7m | +29% |
| Unedrlying revenue growth | +14% | (4)% | |
| Adjusted operating margin | £43.2m | £30.4m | +42% |
| Free cash flow | 23.9% | 21.8% | +210bps |
FY 2021 highlights
- Strong underlying growth of 14%.
- Build-out of European footprint provides diversification and growth opportunities.
- Very positive performance from Scandinavian acquisitions.
- Disciplined portfolio management: Q4 disposal of a1-CBISS.
Our businesses
Principal segments1
